Treatment of Pilonidal Sinus Disease Using Surgiflo as a Sealant: A New Concept

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02638064

Enrollment

Registered

2015-12-22

Start date

2013-03-31

Completion date

2015-11-30

Last updated

2015-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pilonidal Sinus Disorder

Brief summary

Assessment of surgiflo injection for treating pilonidal sinus disease

Detailed description

Evaluation of injection of Surgiflo as a sealent in treatment of pilonidal sinus, evaluation includes recurrence, infection, complications and patient satisfaction over 2 years of follow up

Interventions

PROCEDURESurgiflo injection

Curettage of sinus cavity then injection of surgiflo material

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

14 Years to 45 Years

Healthy volunteers

Inclusion criteria

Patients included in the study had simple midline PS with single or multiple tracts and no lateral extensions. Recurrent cases of PS after previous surgery were also included in the study

Exclusion criteria

We excluded from the study patients with severe scarring at the natal cleft due to previous surgery or infection and patients with signs of an acute abscess.

Design outcomes

Primary

Measure	Time frame	Description
Recurrence of the condition	2 years	number of patients presenting with recurrent pilonidal sinus

Secondary

Measure	Time frame	Description
Complications of the procedure	2 years	number of patients presenting with complications after injection of surgiflo

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026